FEMY FEMASYS INC

Nasdaq femasys.com


$ 0.55 $ -0.04 (-6.78 %)    

Wednesday, 15-Oct-2025 10:42:18 EDT
QQQ $ 606.26 $ 2.40 (0.4 %)
DIA $ 465.96 $ 1.32 (0.28 %)
SPY $ 669.17 $ 2.41 (0.36 %)
TLT $ 91.10 $ 0.13 (0.14 %)
GLD $ 386.28 $ 0.32 (0.08 %)
$ 0.5897
$ 0.59
$ 0.55 x 400
$ 0.56 x 100
$ 0.54 - $ 0.59
$ 0.31 - $ 1.80
1,745,664
na
nm
$ 0.38
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 03-27-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-28-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-10-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 03-30-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-10-2022 06-30-2022 10-Q
14 05-11-2022 03-31-2022 10-Q
15 03-24-2022 12-31-2021 10-K
16 11-12-2021 09-30-2021 10-Q
17 08-11-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 femasys-partners-with-kebomed-to-commercialize-fembloc-permanent-birth-control-in-france-and-benelux-region

Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more acce...

 femasys-partners-with-medical-electronic-systems-to-provide-advanced-sperm-analysis-technology

Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more acces...

 femasys-launches-femsperm-insemination-prep-kit-to-boost-gynecologist-adoption-of-femaseed-fertility-treatment

Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more acces...

 femasys-receives-approval-from-new-zealands-medsafe-for-its-fembloc-permanent-birth-control

Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more acces...

 femasys-secures-uk-mhra-approval-for-fembloc-non-surgical-birth-control-advancing-european-expansion-strategy

Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more acces...

 hc-wainwright--co-maintains-buy-on-femasys-lowers-price-target-to-8

HC Wainwright & Co. analyst Emily Bodnar maintains Femasys (NASDAQ:FEMY) with a Buy and lowers the price target from $12...

 femasys-q2-eps-016-inline-sales-409268k-miss-1025m-estimate

Femasys (NASDAQ:FEMY) reported quarterly losses of $(0.16) per share which met the analyst consensus estimate. This is a 23.81 ...

 femasys-secures-first-commercial-entry-into-europe-with-an-order-of-400k-for-fembloc-permanent-birth-control-in-spain

Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more acces...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION